TITLE:
Research on Applications of Shenmai Injection on Hypertensive ICH Combined with Cerebrocardiac Syndromes
AUTHORS:
Gang Yang, Jianju Feng, Shaojun Yang, Junjie Lv, Donghai Yuan, Chenbing Wang, Feng Ding, Chao Gu, Gaofeng Shao
KEYWORDS:
Hypertensive ICH, Cerebrocardiac Syndromes, Shenmai Injection
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.9 No.5,
May
26,
2021
ABSTRACT: Objective: This study is to observe the therapeutic effects of Shenmai injection on patients with hypertensive ICH and cerebrocardiac syndromes as well as its effects on prognosis. Methods: A total of 72 patients with severe hypertensive ICH and cerebrocardiac syndromes were selected and divided into the control group and the experimental group (Shenmai injection group) randomly, 36 patients in each group. The control group was treated by conventional therapy, while the experimental group was administrated by intravenous drip of the mixture of 50 ml Shenmai injection and 250 ml 5% glucose injection based on the treatment of the control group, once everyday, 2 weeks continuously. Results: Myocardial enzyme indexes of two groups at 3d, 7d and 14d were observed (Table 1). Myocardial enzyme index of the experimental group was improved quickly and significantly. Myocardial enzyme data of two groups at 3d, 7d and 14d were P Conclusions: Shenmai injection has some therapeutic effects on cerebral injuries and myocardial damages. It can treat brain and heart simultaneously, realize the goal of addressing both symptoms and root causes, and improve prognosis of patients with severe hypertensive ICH.